Drug Shortage Report for IDARUBICIN
| Report ID | 219730 |
| Drug Identification Number | 02410028 |
| Brand name | IDARUBICIN |
| Common or Proper name | IDARUBICIN |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | IDARUBICIN HYDROCHLORIDE |
| Strength(s) | 1MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 1X20 ML |
| ATC code | L01DB |
| ATC description | CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-04-15 |
| Actual start date | |
| Estimated end date | 2024-09-02 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-04-16 |
| Company comments | Other presentation available |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2024-04-16 | English | Compare |
| v2 | 2024-02-15 | French | Compare |
| v1 | 2024-02-15 | English | Compare |
Showing 1 to 3 of 3